Page last updated: 2024-10-17

bupropion and Parodontosis

bupropion has been researched along with Parodontosis in 1 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Research Excerpts

ExcerptRelevanceReference
"Smokers willing to quit underwent an 8-week smoking cessation intervention combining individual-based counseling and nicotine replacement therapy and/or bupropion, provided by a general internist."5.14A pilot study combining individual-based smoking cessation counseling, pharmacotherapy, and dental hygiene intervention. ( Abarca, M; Cornuz, J; Gonseth, S; Madrid, C, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gonseth, S1
Abarca, M1
Madrid, C1
Cornuz, J1

Trials

1 trial available for bupropion and Parodontosis

ArticleYear
A pilot study combining individual-based smoking cessation counseling, pharmacotherapy, and dental hygiene intervention.
    BMC public health, 2010, Jun-17, Volume: 10

    Topics: Adult; Attitude to Health; Bupropion; Counseling; Dental Care; Feasibility Studies; Female; Humans;

2010